Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
ASSETS
Cash
Prepaid expenses
Receivable from related party
Related Party
Total receivable from related party
Total Current Assets
Prepaid expenses - non-current
Investments held in Trust Account
Total Assets
LIABILITIES AND SHAREHOLDERS’ DEFICIT
Current liabilities:
Accrued liabilities
Due to related party
Related Party
Total due to related party
Convertible notes related party
Related Party
Nonrelated Party
Total Current Liabilities
Total Liabilities
Redeemable Shares:
Ordinary shares subject to possible redemption, 6,000,000 shares at redemption value of $10.58 per share
Ordinary shares subject to possible redemption, 6,000,000 shares at redemption value of $11.18 and $10.58 per share as of September 30, 2024 and December 31, 2023, respectively
Shareholders’ Deficit:
Ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 2,140,000 shares issued and outstanding on September 30, 2024, and December 31, 2023
Additional paid-in capital
Accumulated Deficit
Total Shareholders’ Deficit
Total Liabilities and Shareholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support